Navigation Links
Other patients bear the real cost of Herceptin

The real cost of Herceptin is borne by other patients whose treatment has to be dropped to balance the books, say doctors in this week’s BMJ.

New guidance from the National Institute for health and Clinical Excellence (NICE) recommends trastuzumab (Herceptin) in early breast cancer, but it provides no extra funding and does not suggest what cuts should be made to release this extra money. This leaves medical staff with difficult decisions to make.

Doctors at the Norfolk and Norwich University Hospital NHS Trust and the University of East Anglia calculated that they will have to find £1.9m each year to make Herceptin available to the patients who may be eligible. This becomes £2.3m if the costs of testing and monitoring patients are added.

But the real cost lies in the services that will be cut to provide this money, they write.

To illustrate this, they audited drug costs in their hospital’s cancer centre and estimated how they could save £1.9m by cutting chemotherapy and palliative care treatments.

The sum of £1.9m would enable us to treat 75 patients with Herceptin, but at four times the cost of the adjuvant treatments, they say. These treatments have been proved to be clinically effective and their estimated cost effectiveness is far greater than that currently expected for Herceptin.

So they could fund Herceptin if they did not treat 355 patients receiving adjuvant treatment (16 of whom would be cured) or 208 patients receiving palliative chemotherapy, and if they found £500,000 from another source.

“These untreated patients will be people we know,?say the authors. “We will be the ones to tell them they are not getting treatment that has been proved to be effective and which costs relatively little, because it is not the treatment of the moment.?

These results are obviously not definitive, but illustrate the fundamental challenge facing the NHS ?the tension between national priority setti
'"/>

Source:BMJ-British Medical Journal


Page: 1 2

Related biology news :

1. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
2. Otherworldly bacteria discovered two miles down
3. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
4. Potential Cure for Lymphoma in HIV patients
5. Ophthalmologists implant five patients with artificial silicon retina microchip
6. Technique may allow cancer patients to freeze eggs, preserving fertility before starting treatment
7. Measuring hormone cuts antibiotic use in half in pneumonia patients
8. Doctors closer to using gene analysis to help trauma patients
9. Research shows smoking adds a decade to reproductive age of IVF patients
10. Columbia study shows widely used artery clearing device does not help patients during heart attack
11. Identification of specific genes predicts which patients will respond to Hepatitis C treatment
Post Your Comments:
(Date:10/3/2008)... New Sales Executives to Focus on Top 100...wire/ -- Kount Inc. ( http://www.kount.com ),a le...hants, has hired,industry veterans Scott Lewer and... Together, they bring Kount customers an unprecede...n ecommerce fraud control and online,payments., S...
(Date:10/3/2008)... , EAST LANSING, Mich. The United States lacks t...m cellulose won,t cause environmental harm, says a...But because the industry is so young, policymakers...ive programs to ensure the industry doesn,t harm t...eeded now, before the industry moves out of its re...
(Date:10/3/2008)... , RIVERSIDE, Calif. Aluminum toxicity, a global..., severely limiting agricultural productivity for ... many years, scientists have puzzled over how toxi...popular understanding is that aluminum binds to se...vision, damaging DNA, and ultimately interrupting ...
(Date:10/3/2008)... , Madison, WI - 5 OCTOBER 2008 - More than 8,000... George R. Brown Convention Center to participate ...ientific societies, Oct. 5-9. A major part of thei...ng sessions highlight research responses to major ..., Where: George R. Brown Convention Center, Hous...
Breaking Biology News(10 mins):Kount Lands Veteran Fraud Experts From Retail Decisions and iovation 2Experts agree: Environmental standards needed for biofuels 2UC Riverside biochemists devise method for bypassing aluminum toxicity effects in plants 2UC Riverside biochemists devise method for bypassing aluminum toxicity effects in plants 3Agricultural research highlighted in Houston 2Rules on Patients Medical Data Hampering Research 6249 1Rules on Patients Medical Data Hampering Research 6249 2Rules on Patients Medical Data Hampering Research 6249 3News Tips from the Journal of Neuroscience 6245 1News Tips from the Journal of Neuroscience 6245 2News Tips from the Journal of Neuroscience 6245 3National Network to End Domestic Violence Fund Introduces New Tool to Outsmart Abusers and Stalkers in Todays High Tech World 6242 1National Network to End Domestic Violence Fund Introduces New Tool to Outsmart Abusers and Stalkers in Todays High Tech World 6242 2Mayo Clinic Supports Store Brand Infant Formulas 6238 1Mayo Clinic Supports Store Brand Infant Formulas 6238 2
...e discovery that cells used in bone marrow transpl..., according to a study by Yale School of Medicine ...nces. , The study showed that bone marrow derived ...stinal epithelial cells after bone marrow transpla... Krause, M.D., professor of Laboratory Medicine an...
...y used to treat a variety of serious infections ma...rding to a test-tube study of human brain cells by...logist Jeffrey Rumbaugh, M.D., Ph.D. , Results of ...presented at the American Academy of Neurology,s 5... , Rumbaugh added that, although ceftriaxone is F...
...es that 70 is the new 60 and 60 is the new 50, unf...tion declining muscle function means it simply isn...y of Auckland,s Faculty of Science aims to develop...ction and quality of life in older individuals. Th...king a stroll followed by a glass of chocolate mil...
...uicide attempts or death by suicide generally decr...idepressant medication, according to a new study l...lished in the January issue of The American Journa...k of suicidal behavior after starting 10 newer ant...d by older medications. , These findings challeng...
Other Biology News:Hopkins study suggests commercially available antibiotic may help fight dementia in HIV patients 2Chocolate milk could be key to longer, healthier life 2Suicide risk does not increase when adults start using antidepressants, study finds 2
(Date:10/3/2008)...Symbol: MS, EDMONTON, Oct. 3 /PRNewswire-FirstCal...loper in the treatment of multiple sclerosis (MS),...Monitoring Board (DSMB) for the,Company,s U.S. piv...8298),in patients with secondary progressive MS ha... the trial continue as per the protocol., This wa...
(Date:10/3/2008)...or Ap3ana, CTI,s ,personalized medicine, venture, ...erapeutics, Inc. (CTI),(Nasdaq: CTIC ) announced ...t recently President and COO of a Tyr Pharma and f...mics Institute of the Novartis Research,Foundation... Bresso, Italy,CTI Europe currently conducts the ...
(Date:10/2/2008)...2 /- Helix BioPharma,Corp. ... its private,placement announced on September 30, ...ss proceeds totaling CDN$11,424,000., Each unit c...mmon share,purchase warrant, with each whole commo...urchase, subject to adjustment, one common share a...
(Date:10/2/2008)...Provides Business Update to Investors, WILMINGTON...today at an,investor conference, DuPont Vice Presi...ny,s plans to bring its two advanced biofuels prog... technical progress toward the,commercialization o...stocks,economically into biofuels., "Biobutanol a...
Breaking Biology Technology:BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 3Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 4Helix Biopharma Closes $11.4 Million Private Placement 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 3
...nbow arches from its HQ all the way to prison. , ...y giant sheds its old image of ENWRONG to PRISMA. ...ny is restructured under the new identity of PRISM... PRISMA Corporation is on a short leash, with a ...g drop from the 2400 business entities during the ...
...s. -- Small Tree Communications , a Midwestern co... tools with a focus on Mac OS X, has announced a f...nk aggregation, an implementation of the IEEE 802...n a computer into one virtual interface, combining...-speed data channel with built-in redundancy. Smal...
... In a bid to spark creation of technology-based bu...tate, the Wisconsin Technology Council voted las...ndustry cluster in Northern Wisconsin. , ,A resolu...or the cluster was unanimously supported by the di...ent, non-profit science and technology adviser to ...
...ge is pretty easy. If you,re the new exec, people ...rt, the vendor list, or in some "key business proc...u don,t have to wait too long before there,s an up...t, and the change beast is off rummaging through t...t, the clamor begins with the focus groups and Pos...
Other Biology Technology:Why is Enron now called Prisma? 2Why is Enron now called Prisma? 3Tech Council passes E-Learning efforts for Northern Wisconsin 2Domesticating the change beast 2Domesticating the change beast 3
...he GrabIt™ Kits are designed for the study o...ls using a pull-down method. Proteins that interac... T7•Tag ® fusion proteins are copurified...exes are retained on a spin filter. The complexes ...
Rabbit anti-Wilm's tumor, Polyclonal Antibody, Unconjugated Applications: IHC-P: Use at a dilution of 1/100. IP: Use at an assay dependent dilution. WB: Use at an assay dependent dilution. P
Kit containing MACS equipment and reagents for immunopurification of proteins.
Membrane Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available.
Biology Products: